HBV resistence to nucleoside or nucleotide analogues

被引：0
|
作者：
Thibault, Vincent [1 ]
机构：
[1] Grp Hosp Pitie Salpetriere CERVI, Virol Lab, F-75651 Paris 13, France
来源：
VIROLOGIE | 2010年 / 14卷
关键词：
HEPATITIS-B-VIRUS; ADEFOVIR DIPIVOXIL; LAMIVUDINE TREATMENT; LIVER-TRANSPLANTATION; POLYMERASE MUTATIONS; VIROLOGICAL RESPONSE; RESISTANCE; SELECTION; EMERGENCE; MUTANTS;
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：S35 / S50
页数：16
相关论文
共 50 条
  • [21] Nucleos(t)ide analogues altered quasispecies composition of hepatitis B virus (HBV)-resistant mutations in serum HBV DNA and serum HBV RNA
    Liao, Hao
    Zhang, He
    Shao, Jinman
    Li, Xiaoyong
    Zheng, Wei V.
    Li, Le
    Yu, Guangxin
    Si, Lanlan
    Zhou, Tao
    Yao, Zengtao
    Dai, Jiuzeng
    Xu, Dongping
    Cheng, Guanxun
    Qu, Jiuxin
    Liu, Yan
    Chen, Junhui
    Lu, Fengmin
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (03)
  • [22] HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation
    Kasraianfard, Amir
    Watt, Kymberly D.
    Lindberg, Lance
    Alexopoulos, Sophoclis
    Rezaei, Nima
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2016, 35 (04) : 312 - 324
  • [23] Nucleoside Analogues as Antibacterial Agents
    Thomson, Jessica M.
    Lamont, Iain L.
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [24] Synthesis and biological evaluation of nucleoside analogues than contain silatrane on the basis of the structure of acyclovir (ACV) as novel inhibitors of hepatitis B virus (HBV)
    Han, Anyue
    Li, Lingna
    Qing, Kuiyou
    Qi, Xiaolu
    Hou, Leping
    Luo, Xintong
    Shi, Shaohua
    Ye, Faqing
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (05) : 1310 - 1314
  • [25] Nucleos(t)ide analogues causes HBV S gene mutations and carcinogenesis
    Wang, Meng-Lan
    Tang, Hong
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2016, 15 (06) : 579 - 586
  • [26] Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy
    Yeh, Chau-Ting
    ANTIVIRAL THERAPY, 2010, 15 (03) : 471 - 475
  • [27] Distinct notch signaling expression patterns between nucleoside and nucleotide analogues treatment for hepatitis B virus infection
    Wang, Zijing
    Kawaguchi, Kazunori
    Honda, Masao
    Sakai, Yoshio
    Yamashita, Tatsuya
    Mizukoshi, Eishiro
    Kaneko, Shuichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 501 (03) : 682 - 687
  • [28] Application of nucleoside analogues to liver transplant recipients with hepatitis B
    Song, Zhuo-Lun
    Cui, Yu-Jun
    Zheng, Wei-Ping
    Teng, Da-Hong
    Zheng, Hong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (42) : 12091 - 12100
  • [29] Long-term consequences of stopping HBIG and/or nucleotide analogues in liver transplant recipients administered hepatitis B vaccination to prevent HBV reinfection
    Duan, Bin-Wei
    Tian, Lan-Tian
    Lin, Dong-Dong
    Zhang, Jing
    Guo, Qing-Liang
    Wu, Ju-Shan
    Zeng, Dao-Bing
    Lu, Shi-Chun
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 : 85 - 89
  • [30] Application of nucleoside analogues to liver transplant recipients with hepatitis B
    Zhuo-Lun Song
    Yu-Jun Cui
    Wei-Ping Zheng
    Da-Hong Teng
    Hong Zheng
    World Journal of Gastroenterology, 2015, 21 (42) : 12091 - 12100
12345